Antimicrobial peptides from C-terminal amphipathic region of E. coli FtsA

Area of Science:

• Microbiology
• Biochemistry
• Immunology

Background:

• Antimicrobial peptides (AMPs) are crucial for innate immunity but underutilized compared to conventional antibiotics.
• The rise of multidrug-resistant (MDR) bacteria necessitates novel therapeutic strategies.
• Bacterial protein membrane-binding regions present a potential source for new antimicrobial agents.

Purpose of the Study:

• To identify and characterize antimicrobial peptides from the E. coli FtsA protein.
• To evaluate the efficacy of these peptides against pathogenic bacteria and fungi.
• To investigate the mechanism of action of the identified peptides.

Main Methods:

• Bioinformatic analysis to identify potential peptide sequences from E. coli FtsA.
• Synthesis and purification of 11- and 13-residue peptides.
• Antimicrobial susceptibility testing against E. coli, MRSA, and C. albicans.
• Membrane binding studies using tryptophan fluorescence.
• Membrane permeabilization assays.

Main Results:

• Identified potent antimicrobial peptides from the C-terminal amphipathic helix of E. coli FtsA.
• Peptides showed significant activity against E. coli, gentamicin-resistant MRSA, and C. albicans.
• Antimicrobial activity was largely unaffected by salt and divalent cations.
• Peptides demonstrated preferential binding to negatively charged membranes.
• Effective permeabilization of E. coli outer and inner membranes at low concentrations.

Conclusions:

• Novel antimicrobial peptides can be derived from bacterial proteins like E. coli FtsA.
• These peptides exhibit broad-spectrum activity and robust membrane-disrupting capabilities.
• The findings suggest a promising new class of antimicrobials for combating MDR infections.